<SEC-DOCUMENT>0001144204-18-053015.txt : 20181009
<SEC-HEADER>0001144204-18-053015.hdr.sgml : 20181009
<ACCEPTANCE-DATETIME>20181009164022
ACCESSION NUMBER:		0001144204-18-053015
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180928
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181009
DATE AS OF CHANGE:		20181009

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		181114075

	BUSINESS ADDRESS:	
		STREET 1:		3333 LEE PARKWAY
		STREET 2:		SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219
		BUSINESS PHONE:		2149055100

	MAIL ADDRESS:	
		STREET 1:		3333 LEE PARKWAY
		STREET 2:		SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>tv504495_8ka.htm
<DESCRIPTION>8-K/A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amendment No. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(D) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<B>October 5, 2018 (September 28, 2018)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B><U>ABEONA
THERAPEUTICS INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Delaware</U></B></FONT></TD>
    <TD STYLE="width: 34%; text-align: center"><P STYLE="margin: 0pt 0"><B><U>001-15771</U></B></P>


</TD>
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>83-0221517</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1330 Avenue of the Americas, 33rd Floor,
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10019 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>(646) 813-4712</U></B><BR>
(Registrant&rsquo;s telephone number, including area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>N/A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see<I>&nbsp;</I>General
Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#9;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="font-size: 10pt"><B>Item 5.02.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a correction, clarifying the disclosure
by Abeona Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;) in its Current Report on Form 8-K dated October 4, 2018 (assigned
a filing date of October 5, 2018) (the &ldquo;<U>Original Form 8-K</U>&rdquo;), Stephen B. Thompson, the Company&rsquo;s Senior
Vice President Finance and Administration, Chief Accounting Officer (principal financial officer), Treasurer, and Secretary, notified
the Company on October 5, 2018 (not as previously reported as September 28, 2018, when the terms of his retirement were only being
considered and discussed), that he will retire from the Company effective December 31, 2018 and has agreed to assist the Company
until such time to ensure a smooth transition. The Company and Mr. Thompson finalized to the terms of Mr. Thompson&rsquo;s retirement
and transition plan and entered into a letter agreement to memorialize such agreement, a copy of which is filed herewith as Exhibit
10.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the letter
agreement, among other things, Mr. Thompson will perform such transition duties as may be requested by the Company. Mr.
Thompson will receive his current annual base salary through December 31, 2018 and will receive a pro-rated target bonus. Mr. Thompson will also have up to twelve months (or the earlier expiration) to
exercise all vested stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as set forth above, there are no
changes or updates to disclosures reported in the Original Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(d) Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 9%"><FONT STYLE="font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><A HREF="tv504495_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="tv504495_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Letter of Agreement dated October 5, 2018 by and between the Company and Stephen B. Thompson</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><B>SIGNATURE</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Abeona Therapeutics Inc.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-bottom: black 1pt solid; padding: 0; text-indent: 0">/s/ Stephen B. Thompson</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; width: 50%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0; width: 5%">Name: </TD>
    <TD STYLE="width: 42%">Stephen B. Thompson</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P></TD>
    <TD>Sr.
Vice President Finance and Administration</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD>Chief Accounting Officer </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: October 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tv504495_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA ELECTRONIC MAIL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 5, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stephen Thompson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Steve:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Congratulations once again on your retirement. I want to thank
you for your years of service and many contributions. This letter of agreement outlines the terms of your separation from employment
with Abeona Therapeutics Inc. (the &ldquo;Company&rdquo;), which will be further agreed to in a definitive separation agreement
containing all the terms and conditions of your separation (&ldquo;Separation Agreement&rdquo;). You and the Company agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD><B><U>Separation Date; Transition Period</U></B> - Your effective date of separation from the Company will be December 31,
2018 (the &ldquo;Separation Date&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">The period between the date you
execute the Separation Agreement with the Company and the Separation Date will be a transition period (the &ldquo;Transition Period&rdquo;),
during which time you agree to reasonably assist the Company with the transition of your job duties and to perform any other transition
duties as may be reasonably requested by the Company (collectively, the &ldquo;Transition Duties&rdquo;). The Company shall maintain,
at the Company&rsquo;s cost and expense, your current level of benefits (health/medical and any other applicable benefits) and
salary at all times during the Transition Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD><B><U>Compensation/Severance Benefits</U></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The Company will pay your current annual base salary through the Separation Date in accordance with the Company&rsquo;s usual
payroll guidelines and practices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>Within sixty (60) days following the Separation Date, you will be paid an additional amount equal to your pro-rated target
bonus for the period ending the date of the Separation Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>You will further be paid for any accrued but unused vacation days, and will be reimbursed for previously submitted, but un-reimbursed,
business expenses in accordance with the Company&rsquo;s usual guidelines and practices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>All stock options that have vested as of the Separation Date, if any, must be exercised by the earlier of 12 months of the
Separation Date or the expiration of the option.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Once again, congratulations and
best of luck in your retirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">Very truly yours,<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Abeona Therapeutics, Inc.<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; white-space: nowrap">By:</TD>
    <TD STYLE="width: 2.5in; border-bottom: Black 1pt solid; padding-left: 0.125in">/s/ Carsten Thiel</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>F. Carsten Thiel, Ph.D.</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">I hereby agree to the terms and conditions set forth
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0; text-align: right"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; white-space: nowrap; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 2.5in; border-bottom: Black 1pt solid; padding-left: 0.125in">/s/ Stephen Thompson</TD>
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD>Date <U>&nbsp;&nbsp;&nbsp;&nbsp;10/5/18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Stephen Thompson</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z FD# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SWC.ZNK305>SEECF>YACS$P5B&< @$\#/K70T
MA4,,$ _6KIR49*35[$5(N47%.USSE[_Q+HU\'N)4ED@L+BY,-S*6_=*X*@E
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MK6U]J]BMY!%"EK#+;HI*2DE\$AOPY]L>]2ZGXXU/2UEMYK*U:[BNS \BL?)
M\L..21R=V.3VKNF1&.652>G(H,:,"&12#R<CK35>G9*4+V$Z%2[<9VN<KKFN
MW#>'M-\GS[:\U,I_Q[+YTD2XW.RA<[L#^=94/C;5/[,B\J"WDN+:RFFO/M.Y
M6#1,%88'0D$'GIFO0-JC'RCC@<=*3RTR3L7)Z\=:4:U-*SA?^O\ (<J-1RNI
MV_K_ #."OO'>IZ?'+%-8VOV@218=&8Q(DB%QN)QSQCJ!1=>+=6N]*OYX[>WM
MXK:UAED*2DR;I/[K#(QQU]*[TQH0044@]<CK1Y: $;%P>",4U7I*WN:DNA5=
M_P!YH<7<^-+FW&JMMLD%F[1)!(SF;AE7>X'&TYR#D=N:KV/CZ[NI=+5[:U07
M,S12X<ELA]H*J.W?//\ 6N\,:$DE%)88/'6FM!$RE3&N,$=/7K0JM*UG#^K?
MTQNC6O=3_#S_ *1B:WJ<,_AS[99:DD,<C@1S^<(E;G!&\JVWH><=JXR?Q%J0
M\.:5=_VM,+H?ZR,NJO*/-QE4V_O<CCJ/7O7IL5M!!;);Q1(D**%6,+\H [8I
M^Q#MRJ_+TXZ4J=>$%;EOKY?Y!4H3F[\UM//_ #.7DT;6Y[VSEDO2\*7(F=#,
M0 !*2!C'/R;1CL1WK"U&]U5X_%-P+B^$-JTL<4B7"K''A5(&W&[//7->CTFQ
M<$;1@]>.M$,19ZI/_A[CGAKK1M?\-8XI?&=W'JGV06T$B),8#;AF^TD"/=YN
M,8VFJL/CS49X1Y5M8322B J8G<I"TC[?+D/9AG/'Y5W^Q=V[:-V,9QS2"-!G
M"*,G/3O3]M2_D%[&K_.<MXDN=:BFT2*SG5+QS(\L<?W)BB;BG/.#@@?6N=7Q
M_?VMKYT4 N%N+JX9&N6V!$4C$><@ \]_UKTP@$@D#(Z'TIIBC9=IC4C.<$=Z
M(5X**4H7_IA.A4<G*,[?TCA[OQ]=6%U+%<Z>H6W9C<%"3L1E!A(]2Q.#5_Q#
M?:S9:)I^K0R)%=#;'/;9_=LTH"CW^5B#^==48T.<HISUXZTI 88(!'O4^VII
MIJ&V_F/V-1IISWV\C@8_%VH:;.UA)Y%T]L\ENPD=OM#%$+><P QL)'Y$<U%)
MXGU>VU:PO+E8 MW8(^U'?R(%>1<.XZY .,CU':O0MB%BVU<D8)QVH,:$8*+T
MQT[>E7[>G_(2\/4_G,'Q%JH;PIJ=UIMWB2',7FQ]4<, <9]*YS^TM<GO[W3V
MOI(;W3-/$CG&$E=),ACQT=,9^OM7>P6EO:VX@@A2.($G8HXY.3^M2[5R3M&2
M,$XJ(5HP32C?U^7_  ?O*G1E-IN5O3Y_\#[CGM(GN9O"K:EJ&I?9WO%^T^9E
M=MLC8*JN1C &.3W)KD8_$MU<>'M):;7)+=6M[EIKE&7<\Z'Y(V.#C@YQWKT\
MJI7:5&W&,8XIOE1A=OEIC.<8[TX5XIMN/7R_R%.A)I)2Z>>OXGG-EK^K3ZG:
M?:M0EAOVNH86L-@"^0T09Y"N,]23G.!C%":_>2Z3J:PZ\DOD:IM:9KB.-S;X
M'W&(VC)S@_6O2-BEMVT;L8SCFF^3$ 0(DP>HVBK^LP_D_+_(GZM/^?\ /_,Q
M?!]W>WWAJVN+\NTK%]KO]YT#':3C';'/?K6[1THKEG)2DY)6N=4(N,5%N]@J
MM//<1R;8K-I5Q]X.H_F:LT4DRBE]KO/^@:__ ']3_&C[7>?] U_^_J?XU=HI
MW785GW*7VN\_Z!K_ /?U/\:/M=Y_T#7_ ._J?XU=HHNNP6?<I?:[S_H&O_W]
M3_&C[7>?] U_^_J?XU=HHNNP6?<I?:[S_H&O_P!_4_QH^UWG_0-?_OZG^-7:
M*+KL%GW*7VN\_P"@:_\ W]3_ !H^UWG_ $#7_P"_J?XU=HHNNP6?<I?:[S_H
M&O\ ]_4_QH^UWG_0-?\ [^I_C5VBBZ[!9]RE]KO/^@:__?U/\:/M=Y_T#7_[
M^I_C5VBBZ[!9]RE]KO/^@:__ ']3_&C[7>?] U_^_J?XU=HHNNP6?<I?:[S_
M *!K_P#?U/\ &C[7>?\ 0-?_ +^I_C5VBBZ[!9]RE]KO/^@:_P#W]3_&C[7>
M?] U_P#OZG^-7:*+KL%GW*7VN\_Z!K_]_4_QH^UWG_0-?_OZG^-7:*+KL%GW
M*7VN\_Z!K_\ ?U/\:/M=Y_T#7_[^I_C5VBBZ[!9]RE]KO/\ H&O_ -_4_P :
M/M=Y_P! U_\ OZG^-7:*+KL%GW*7VN\_Z!K_ /?U/\:/M=Y_T#7_ ._J?XU.
MUY:HS*US"K*P1@7 (8] ?<]A3#J%D#*#>6X,0)D'FK\F#CGGCFCF78GF7\WY
M$?VN\_Z!K_\ ?U/\:/M=Y_T#7_[^I_C4QOK03&$W4/F@9*>8-V,9SCZ<TZ.Z
MMYF58IXG+)YBA7!RO]X>WO1S+L%UW_(K_:[S_H&O_P!_4_QH^UWG_0-?_OZG
M^-5U\06+ZC=V*&0SVL9D;Y<*V ,A3W(R,U+IVM6.I6"W45Q$H\L22(9%S$",
M_-SQ2YX]B%5A)V4OZ6X_[7>?] U_^_J?XT?:[S_H&O\ ]_4_QIYU.P6V%R;Z
MV$!.T2F5=I/IG.*5]1L8W1'O;=6< H&E4%L],<\YHYEV*YX_S?D1_:[S_H&O
M_P!_4_QH^UWG_0-?_OZG^-++J=JAECCE6>XB!+6\+!I/^^<UE1^+[*1(Y/LU
MW'"]P+<RS($56Y!R2>V#FASBNA$JU.#M*1J?:[S_ *!K_P#?U/\ &C[7>?\
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M/\:NT4778+/N4OM=Y_T#7_[^I_C1]KO/^@:__?U/\:NT4778+/N4OM=Y_P!
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MU8@DDDCW2PF%LXVE@?Y5+12;78+!1112&%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
